Pay in 4 interest-free payments of $7.08 Learn more
Ships within 48 hours · Estimated delivery Nov 4 - Nov 9
Side Effects & Safety Transient headache -- the most commonly reported side effect Mild nausea -- usually resolves within 30 minutes Temporary dizziness/vertigo -- reported at higher doses Injection site redness -- standard for SC peptides No lethal dose identified in animal studies No dependency or withdrawal documented No respiratory depression -- unlike pharmaceutical sleep aids DSIP appears on the FDA's list of bulk drug substances that raise potential safety concerns
HDAC11 mediates the ubiquitin-dependent degradation of p53 and inhibits the anti-leukemia effect of PD0166285
J Biol Chem 281 : 41834189
Hygiene and correct dosage help to reduce dangers
US$ 22.67
US$ 23.56
US$ 26.18
